Alcon AG
SIX:ALC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (35.9), the stock would be worth CHf77.17 (23% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 29.3 | CHf62.86 |
0%
|
| 3-Year Average | 35.9 | CHf77.17 |
+23%
|
| 5-Year Average | 38.3 | CHf82.36 |
+31%
|
| Industry Average | 24.1 | CHf51.72 |
-18%
|
| Country Average | 19.5 | CHf41.96 |
-33%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
CHf31.8B
|
/ |
Jan 2026
$1.4B
|
= |
|
|
CHf31.8B
|
/ |
Dec 2026
$2.2B
|
= |
|
|
CHf31.8B
|
/ |
Dec 2027
$2.5B
|
= |
|
|
CHf31.8B
|
/ |
Dec 2028
$2.8B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| CH |
|
Alcon AG
SIX:ALC
|
30.7B CHF | 29.3 | 39.2 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 34.1 | 39.1 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
62.6B USD | 0 | 0 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
97.7B DKK | 15.8 | 25.3 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.6B USD | 19.8 | 33.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.7B GBP | 19.2 | 35.6 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6B USD | 56.3 | -16.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
927.6B JPY | 33.8 | 52.4 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.3T KRW | -79.9 | -37.7 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.4B USD | 18.2 | 23.2 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
35.7B CNY | 19.3 | 21.6 |
Market Distribution
| Min | 0 |
| 30th Percentile | 13.5 |
| Median | 19.5 |
| 70th Percentile | 25.3 |
| Max | 855.5 |
Other Multiples
Alcon AG
Glance View
Alcon AG, headquartered in Geneva, Switzerland, emerges as a global leader in eye care, having spun off from Novartis in 2019 to operate independently. The company traces its roots back to a small pharmacy established in Fort Worth, Texas, in 1945, gradually expanding under the strategic vision of its founders. Today, Alcon stands at the intersection of innovation and necessity, catering to a world increasingly aware of eye health. The firm specializes in two main sectors: Surgical and Vision Care. In the Surgical division, Alcon offers advanced technologies and devices for ophthalmic surgery, encompassing cataract, retinal, and refractive procedures. Through these innovations, Alcon not only enhances patient outcomes but also streamlines operations for eye care professionals, carving out a significant market share in surgical solutions. Meanwhile, the Vision Care segment thrives by addressing the burgeoning demand for contact lenses and ocular health products. Alcon’s portfolio features daily disposable and reusable lenses, supported by innovative technologies that prioritize comfort and clarity of vision. Additionally, the company provides comprehensive eye care products, including lens care solutions, which enhance user satisfaction and ensure sustained demand. Alcon’s revenue model hinges on its ability to deliver cutting-edge products that meet the evolving needs of consumers and professionals alike. Through strategic investments in research and development and a strong distribution network, Alcon perpetually reinforces its market presence, securing its position as a formidable player in the eye care industry.
